AutoICD API

90919-2

Laboratory

Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag in Plasma by Immunoassay

Definition

This test measures the binding activity of von Willebrand factor (vWF) to Factor VIII as the ratio of the amount of exogenous recombinant Factor VIII bound to vWF in the patient sample to the amount of vWF in the patient sample. It is used to differentiate between various bleeding disorders including hemophilia A and type 2N von Willebrand disease (2N vWD, VWD2N, or Type 2 Normandy). Type 2N vWD is caused by mutations to the Factor VIII binding site of vWF, which results in reduced binding and faster clearance of Factor VIII. Patients with type 2N vWD usually have reduced Factor VIII activity with normal VWF levels. [PMID: 19298374]

LOINC 6-Axis Classification

Component

Coagulation factor VIII.recombinant.bound/von Willebrand factor Ag

Property

RelRto

Time Aspect

Pt

System

Plas

Scale Type

Qn

Method Type

IA

Details

Class

COAG

Order/Observation

Both

Short Name

Fact VIII.recomb.bound/vWF Ag Plas IA

Display Name

Bound rFVIII/vWf Ag IA (P) [Relative ratio]

Related Names

AHFAHGAntihemophilic factorAntihemophilic globulinAssociatedbndCirculating anticoagulantCoagEIAELFAELISAEnzyme immunoassayF8FacFactFact VIIIFact VIII.recomb.boundFactor 8Factor VIII clotting activityFVIIIHematologyHemeIAAMEIANormandyPlPlasmaPlsmPoint in timeQNTQuanQuantQuantitativeRandomRelative ratioSUDSThrombocyte cofactor AType 2 NormandyVIII:CVon willVonwillebrandvWfvWF:Ag

Frequently Asked Questions

What is LOINC code 90919-2?

LOINC code 90919-2 identifies "Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag in Plasma by Immunoassay". This test measures the binding activity of von Willebrand factor (vWF) to Factor VIII as the ratio of the amount of exogenous recombinant Factor VIII bound to vWF in the patient sample to the amount of vWF in the patient sample. It is used to differentiate between various bleeding disorders including hemophilia A and type 2N von Willebrand disease (2N vWD, VWD2N, or Type 2 Normandy). Type 2N vWD is caused by mutations to the Factor VIII binding site of vWF, which results in reduced binding and faster clearance of Factor VIII. Patients with type 2N vWD usually have reduced Factor VIII activity with normal VWF levels. [PMID: 19298374]

What does 90919-2 measure?

This code measures Coagulation factor VIII.recombinant.bound/von Willebrand factor Ag in Plas. It belongs to the COAG class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.